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The myogenic determination genes Myf5, Myod and Mrf4 direct skeletal muscle cell fate prenatally. In adult myogenesis, Myod has been
shown to regulate myoblast differentiation, however, our understanding of satellite cell regulation is incomplete since the roles of Myf5 and Mrf4
had not been clearly defined. Here we examine the function of Myf5 and Mrf4 in the adult using recently generated alleles. Mrf4 is not expressed
in normal or Myf5 null satellite cells and myoblasts, therefore excluding a role for this determination gene in adult muscle progenitors. Skeletal
muscles of adult Myf5 null mice exhibit a subtle progressive myopathy. Crucially, adult Myf5 null mice exhibit perturbed muscle regeneration with
a significant increase in muscle fibre hypertrophy, delayed differentiation, adipocyte accumulation, and fibrosis after freeze-injury. Satellite cell
numbers are not significantly altered in Myf5 null animals and they show a modest impaired proliferation under some conditions in vitro. Mice
double mutant for Myf5 and Dystrophin were more severely affected than single mutants, with enhanced necrosis and regeneration. Therefore, we
show that Myf5 is a regulator of regenerative myogenesis and homeostasis, with functions distinct from those of Myod and Mrf4.
© 2007 Elsevier Inc. All rights reserved.Keywords: Satellite cell; Myogenic regulatory factors; Myf5; Mrf4; Myod; Pax7; Regeneration; Stem cell; Freeze-injuryIntroduction
The basic helix–loop–helix transcription factors Myf5,
Myod, Myogenin and Mrf4 form the myogenic regulatory
factor (MRF) family (Tajbakhsh and Buckingham, 2000;
Weintraub et al., 1991). In the embryo, Myf5, Myod and Mrf4
can individually direct muscle cell fate from somatic multi-
potent muscle progenitor cells (MPCs), and mice triple mutant
for these genes totally lack differentiated fibres and myoblasts,
thus identifying them as the determination genes for this lineage
(Kablar et al., 2003; Kassar-Duchossoy et al., 2004; Rudnicki et
al., 1993; Tajbakhsh et al., 1996). In the absence ofMyf5, MPCs⁎ Corresponding author. Fax: +33 1 45 68 89 63.
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doi:10.1016/j.ydbio.2007.08.059are developmentally arrested until Myod or Mrf4 programmes
muscle identity, otherwise, they can adopt alternate cell fates
(Kassar-Duchossoy et al., 2004; Tajbakhsh et al., 1996). In
addition, Mrf4, Myod (Rawls et al., 1998) and Myogenin
(Hasty et al., 1993; Nabeshima et al., 1993) can direct muscle
cell differentiation from myoblasts, however, Myf5 alone is
unable to do so (Valdez et al., 2000). This has lead to the
proposal that Myf5 acts only in MPCs and myoblasts (Kitzmann
et al., 1998; Tajbakhsh and Buckingham, 2000; Yablonka-
Reuveni et al., 1999; Yoshida et al., 1998). The paired/
homeobox transcription factors Pax3 and Pax7 are also key
regulators of myogenesis, and their expression marks myogenic
ancestors in the embryo, which later give rise to postnatal
muscle progenitors called satellite cells (Ben-Yair and
Kalcheim, 2005; Gros et al., 2005; Kassar-Duchossoy et al.,
2005; Relaix et al., 2005).
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after multiple rounds of injury. The functional unit of skeletal
muscle is the myofibre, a polynucleated contractile structure
which is post-mitotic and therefore dependent on new myo-
nuclear input for continued growth and repair. Satellite cells are
the principal cell type assuring postnatal skeletal muscle growth
and regeneration (Collins et al., 2005; Mauro, 1961; Moss and
Leblond, 1971). They reside on adult muscle fibres and are
located between the plasmalemma of the myofibre and the
basement membrane, whereas myonuclei are located within the
myofibre, Adult quiescent satellite cells can be further
distinguished from myonuclei by marker gene expression
including Pax7 and Myf5nlacZ (Seale et al., 2000; Beauchamp
et al., 2000; Tajbakhsh et al., 1996). Satellite cells enter the cell
cycle upon activation by work overload, or trauma such as
injury, and they generate a pool of myoblasts which terminally
differentiate by fusing homotypically or with existing myofi-
bres. Behavioural heterogeneity has been described for the
satellite cell population, and it has been suggested that
sublaminal cells are not functionally equivalent (Cossu and
Tajbakhsh, 2007; Kuang et al., 2007; Sherwood et al., 2004;
Zammit et al., 2006).
The respective roles of the key transcriptional regulators
which act postnatally during growth as well as regeneration
need to be resolved.Myod−/− adult mice are reduced in size and
have an increased number of satellite cells and myoblasts
(Megeney et al., 1996; Sabourin et al., 1999; White et al., 2000;
Yablonka-Reuveni et al., 1999), suggesting that the balance
between self-renewal and differentiation is deregulated. Myod
null mice are also delayed in muscle regeneration (Megeney et
al., 1996; White et al., 2000). Interestingly, mice double mutant
for Dystrophin, which links the cytoskeleton to the extracellular
matrix, and Myod, have a severe myopathic phenotype and they
die prematurely (Megeney et al., 1996). Significantly, Pax7 null
mice are deficient in satellite cells, with postnatal muscle
growth severely retarded (Kuang et al., 2006; Oustanina et al.,
2004; Relaix et al., 2006; Seale et al., 2000). These and other
studies have demonstrated the importance of examining mutant
mice, not only during normal growth, but also during muscle
regeneration (Cornelison et al., 2004; Floss et al., 1997;
Megeney et al., 1996; Zhao et al., 2006). Notably, although
Pax7 and Myod have been identified as key regulators of
satellite cell self-renewal and differentiation, the mechanism by
which they act remains largely unresolved.
The role of Myf5 in postnatal myogenesis is not clearly
defined, since previously described Myf5 null alleles resulted in
perinatal lethality (Braun et al., 1992; Tajbakhsh et al., 1996). It
is therefore of importance to resolve the relative roles of the key
myogenic regulators in satellite cells during skeletal muscle
growth and regeneration. Given that Myf5 and Mrf4 play
critical roles in governing muscle cell fate in the embryo, we
examined their roles in adult muscle and satellite cells. A new
generation of Myf5 and Mrf4 mutant mice (Kassar-Duchossoy
et al., 2004) has permitted the investigation of these genes in the
adult. Notably, the Myf5loxP allele is homozygous viable and
does not affect expression of the Mrf4 gene located in cis at a
distance of 9 kbp. We report here that Myf5 null mutants arecharacterised by a subtle progressive myopathy and muscle
regeneration deficits. Furthermore, these were exacerbated after
acute injury or in a genetic model for muscle myopathy. In
addition, we show that Mrf4 does not act in satellite cells and
myoblasts in normal and Myf5 null animals. Therefore our
findings reveal that Myf5 is necessary for efficient regenerative
myogenesis and conclude that Myod and Myf5 play distinct
roles in the adult.Materials and methods
Animal models
Knock-out mouse lines, Myf5loxP/loxP, Myf5nlacZ/loxP, and Mrf4nlacZ/+:
Myf5loxP/+, were described previously (Kassar-Duchossoy et al., 2004;
Tajbakhsh et al., 1996).Myf5nlacZ/+ and wild-type animals were used as controls.
Briefly, Myf5loxP mice were obtained by crossing Myf5NeoHygroBC/+ mice with a
zygotic PKG-Cre expressing transgenic. The latter was subsequently segregated
away and the resultingMyf5loxP allele was interbred and crossed to other mutants
to obtain the different genetic combinations described in this study. Although
Myf5nlacZ downregulates Mrf4 expression in cis in embryonic progenitors, this
did not influence our studies on satellite cells since Mrf4 is not expressed until
after differentiation in the adult (see Fig. 6). The Myf5loxP allele contains about
124 bp in the first exon ofMyf5 and this insertion does not affectMrf4 expression
in muscle progenitors in the embryo (Kassar-Duchossoy et al., 2004). Mice were
6 to 10 weeks old unless otherwise indicated, and were generated on a mixed
background C57BL6/129sv/DBA2.Myod null mice were kindly provided byM.
Rudnicki (Rudnicki et al., 1992). Myf5loxP/loxP and Myf5nlacZ/loxP were crossed
with the Dystrophin deficient mice Mdx4cv (Im et al., 1996) to generate double
null Mdx4cv:Myf5loxP/loxP or Mdx4cv:Myf5nlacZ/loxP, respectively. In the Mdx4cv
allele, a C to T transition in exon 53, creates an ochre stop codon (CAA to TAA).
Muscle injury, hypertrophy, necrosis, and fibrosis
Mice were anesthetised with 0.5% Imalgene/2% Rompun and the tibialis
anterior muscle was subjected to three consecutive cycles of freezing–thawing
by applying a liquid nitrogen cooled metallic rod. This procedure results in the
death of N2/3 of the muscle mass and yields a more reproducible injury
compared to a single freeze. Muscles were collected 3, 4 and 7 days after injury;
full regeneration was examined 2–5 weeks after injury. For injury with a
cytotoxic agent, 25 μl of the protein kinase C inhibitor cardiotoxin (10−5 M in
0.9% NaCl, Latoxan) was injected with a Hamilton syringe into the TA. To
evaluate the number of satellite cells, the muscle was collected 18 h after injury
and stained for Pax7 and Laminin.
To evaluate hypertrophic muscle fibres, frozen sections were stained with
anti-laminin antibodies to delimit the fibre. A minimum of 100 fibres/animal
were quantified by measuring the small and large diameter independently using
a Zeiss Axiophot microscope with an Orca ER digital camera using Axiovision
V-02-2001 software. Similar results were obtained, and we report the small
diameter data. Necrotic fibres and regenerating fibres (basophilic fibres) were
evaluated from hematoxylin and eosin-stained paraffin sections. Quantification
of necrotic and regenerating foci was done by counting the number of fields with
a 40× objective and quantified with a reference grid according to the
manufacturer’s instructions (Zeiss). For quantification of fibrosis, muscle
sections were stained using Sirius Red, and scored from 0 to 5: 0=normal
muscle, no staining in endomysium; 1=myofibre surrounded by a non-
continuous staining; 2=myofibres surrounded by a thin but continuous staining;
3=myofibres surrounded by a thick continuous staining; 4= thick endomysium
staining in continuity with perimysium; 5= intense staining replacing the normal
muscle tissue.
Single fibre preparation and satellite cell cultures
Single fibres were isolated as described previously (Zammit et al., 2002).
Briefly, EDL muscles were dissected and treated for 1 h with 0.1% collagenase
15B. Gayraud-Morel et al. / Developmental Biology 312 (2007) 13–28(C-0130, Sigma) at 37 °C. For time zero experiments, fibres were fixed for
5–10 min with 4% PFA/PBS at room temperature. For myoblast cultures,
fibres were plated on Matrigel (BD Biosciences), one single fibre per 24 wells or
kept in suspension in growth medium (10% horse serum (HS) +0.5% chick
embryo extract (CEE), in DMEM, penicillin/streptomycin). Matrigel matrix is a
solubilised basement membrane preparation extracted from EHS mouse
sarcoma, a tumor rich in extracellular matrix proteins. It is composed primarily
of laminin, followed by collagen IV, heparan sulfate proteoglycans, and entactin
(BD Biosciences). In some experiments, dishes were coated with 0.1% gelatin
(Merck) or 0.1% collagen (Type I BD Biosciences). For cell proliferation assays,
about 150 EDL single fibres were plated on Matrigel-coated dishes and the
satellite cells grown for 4 days in a rich proliferating medium containing 40%
MCDB201 medium (Sigma)/40% DMEM/20% FCS/2% Ultroser (Invitrogen).
On the fourth day, they were trypsinized, replated at a density of 15,000 cells/cm2
on Matrigel-coated labtek slides, cultured for 2 days in growth medium, then
fixed with 4% paraformaldehyde and processed for immunostaining. For BrdU
experiments, 2 h before fixation, the medium was replaced by growth medium
containing 5×10−6MBrdU. Formicro-colony assays, myoblasts were expanded
from single fibres as described above, and replated in growth medium at the
density of 100 cells/35 mm poly-D-lysine (Sigma)-coated culture dishes. For the
isolation of satellite cells from bulk muscles, all of the muscles from lower limbs
were dissected, dissociated in trypsin (0.1%)/collagenase (0.1%), filtered through
a 40 μm filter, and the remaining cellular material was plated on 0.1% gelatin-
coated dishes in the presence of growth medium (20% FCS/2% Ultroser) as
described previously (Montarras et al., 2000). Cell cultures were analysed 3 days
after plating (Fig. 5D) or cultured for 4 days, trypsinized, plated at low density,
and grown for an additional 4 days (Supplementary Fig. 2C). For the proliferation
assay, the cells were pulsed with 5×10−6 M BrdU 2 h prior to fixation. For
immunostaining, cells were fixedwith 4%PFA and processed as indicated below.
Phase contrast pictures were taken with a Zeiss inverted microscope.
Antibodies
Antibodies used were: Pax7 (monoclonal, 1/20), Myogenin (monoclonal,
F5D, 1/50) antibodies from Developmental Studies Hybridoma Bank;
Myogenin (polyclonal, 1/200), Myod (polyclonal, 1/200), Mrf4 (Myf6
C-terminal, 1/500) and peroxisome proliferator-activated receptor gamma
(PPARγ, clone H100, 1/100) from Santa Cruz; Myod (monoclonal, 1/50;
Dako), laminin (polyclonal, 1/200) and β-galactosidase (monoclonal, 1/100)
from Sigma, tubulin (monoclonal, 1/1000; Chemicon), anti-β-galactosidase
(polyclonal, 1/500; kindly provided by O. Puijalon and JF Nicolas), anti-
neonatal myosin heavy chain (polyclonal; nMyHC, 1/100; kindly provided by V.
Mouly), anti-phospho-histone 3 (monoclonal, 1/200; Sigma), anti-BrdU
(monoclonal, 1/50; BD). Secondary antibodies used were AlexaFluor anti-
mouse and rabbit 488 and 594 (1/200; Molecular Probes) and anti-mouse Cy-3
(1/200; Jackson ImmunoResearch).
Immunostaining and histology
Myoblast cultures or single fibres were fixed 5 min in 4% PFA,
permeabilized with 0.5% Triton X-100/PBS for 5 min, and washed several
times with PBS before adding the blocking agent (20% goat serum; Gibco).
Primary antibodies were applied o/n at 4 °C, and samples were washed 3 times
with PBS. Secondary antibodies were applied 2 h at room temperature.
For cryostat sections, unfixed muscles were embedded in OCT and frozen
directly in liquid nitrogen. For anti-Myogenin staining on section, the TA was
frozen in cold isopentane. For all experiments, 8 μm frozen sections were
unfixed (nMyHC), or fixed in 1% PFA for 2 min, and treated with 0.1% Triton
X-100 for 20 min. For Pax7 staining, antigen retrieval involved microwave
treatment for 12 min in Antigen Unmasking solution (Vector), cooling 20 min,
blocking 30 min in 20% goat serum/0.1% BSA/PBS. Antigen retrieval was also
done by permeabilising sections in PBS/Triton 0.1% for 20 min, rinsing
3×5 min in PBS, then placing slides in a boiling solution of 10 mM sodium
citrate pH=6 for 5–10 min. The beaker was cooled at room temperature for at
least 30 min and the slides were rinsed 3×5 min in distilled water.
For Oil Red O staining of cryostat sections, 3–4% PFA fixed sections were
rinsed 3× in PBS, quenched with 50 mM NH4Cl/PBS for 10 min, rinsed 3× in
distilled H2O and stained with Oil Red O for 30 min at 37 °C (Stock: 100 mgpowder (Sigma) dissolved in 12 ml triethyl phosphate+8 ml distilled H2O;
Working solution: 7.2 ml stock solution+4.8 ml H2O at 37 °C, filtered 2× with
Whatman paper, then a 0.2-μm filter). Sections were washed 5× in distilled 37 °C
H2O for 3 min each, then mounted for microscopy (Koopman et al., 2001).
For X-gal staining, single fibres or myoblasts were fixed 5 min with 1% PFA,
washed with PBS, stained overnight with X-gal solution (Tajbakhsh et al., 1997).
For histology, muscles were collected in Bouin’s fixative, dehydrated in alcohol,
treated with histoclear, and embedded in paraffin. Paraffin sections (6–8 μm)
were stained by hematoxylin and eosin. Images were acquired with an Zeiss
axiophot microscope and a Zeiss digital colour camera.
Western blot
For Western blot analysis, single fibres were plated on Matrigel-coated
dishes and incubated for 4 days in 10% HS/0.5% CEE/DMEM, trypsinized,
filtered (70 μm) to remove fibres, and replated at the 16,000 cell/cm2. Lysates
were analysed on 10% acrylamide gels as described (Kassar-Duchossoy et al.,
2004).
Statistics
Student’s t test was used to determine statistical significance. The p-values
are indicated in the figure legend for each experiment. Graphs representing
hypertrophy were generated and analysed with the ANOVA test (online: http://
www.physics.csbsju.edu/stats/anova.html).Results
Myf5 null mice (Myf5loxP and Myf5GFP-P alleles) are viable,
and except for the deep back (epaxial) muscles (Kassar-
Duchossoy et al., 2004), they do not exhibit significant deficits
in the major muscle masses. In addition, all four fibre types were
present in Myf5 null muscle (Type IIa, IIb, IIx, Type I; data not
shown) suggesting that Myf5 does not have a selective role in
slow/fast muscle specification. The Myf5loxP and Myf5nlacZ
alleles were used in the present study. The former was obtained
by crossing Myf5NeoHygroBC/+ mice with a zygotic Cre
expressing transgenic, which was then segregated away
(Kassar-Duchossoy et al., 2004). Muscle from young adult
Myf5 null mice was essentially indistinguishable from that from
wild-type. Surprisingly however, in 7 month old animals we
found that fibrosis of the connective tissue (Fig. 1A), a signature
of chronic or repeated cycles of necrosis/regeneration, was
significantly higher in the Tibialis anterior muscle of Myf5 null
animals (level 2/3; n=3 mice; see Materials and methods)
compared to wild-type mice (level 1; n=2 mice). This was
accompanied by an increase in central nucleation (data not
shown), as well as an increase in the diameter (ca. 35%), and
range of myofibre diameter (∼2×; Fig. 1B). These phenotypes
were not accompanied by a detectable increase in neonatal
myosin heavy chain (nMyHC) expression (data not shown),
which identifies newly formed and regenerating muscle fibres
suggesting that this is a subtle yet cumulative defect elicited by
a lack of Myf5.
Mrf4 is expressed only in differentiated myogenic cells in adult
muscles
We showed previously that Mrf4 acts as a determination
gene in the embryo (Kassar-Duchossoy et al., 2004), yet the
Fig. 1. Adult muscle deficits in Myf5 null animals. (A) Sections of TA muscle fromMyf5nlacZ/+ andMyf5loxP/loxP animals stained with Sirius Red reveals the extent of
fibrosis in the connective tissue. (B) TA fibre diameter (μm) was quantified in undamaged 7-month-old wild-type andMyf5loxP/loxPmice.Myf5loxP/loxP fibre diameter is
greater compared with wild-type (pb0.0001). Scale bar: A, 50 μm.
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remained an open question. Furthermore, the upregulation of
Mrf4 in muscle precursors may potentially compensate for
the lack of Myf5 function. To investigate these possibilities,
we examined the expression of β-galactosidase on single
myofibres from Mrf4nlacZ/+:Myf5loxP/+ mice, in which the
highly sensitive β-galactosidase activity reports the expression
of Mrf4. This allele permitted the detection of Mrf4
expression in embryonic muscle progenitor cells (Kassar-
Duchossoy et al., 2004). Fig. 2A shows that satellite cells on
freshly isolated myofibres, the majority of which are quiescent
(Cornelison et al., 2000), are β-galactosidase-negative (n=2
mice; 10–15 fibres/mouse). Furthermore, myoblasts generated
from activated satellite cells remained negative for the
expression of Mrf4nlacZ/+:Myf5loxP/+ for several days until
differentiation commenced (Fig. 2B; data not shown). To
examine the possible upregulation of Mrf4 in Myf5 null
myoblasts, satellite cells from single myofibres were ex-
panded for several days and allowed to differentiate. During
early myoblast growth, Mrf4 expression was not detected by
Western blot (Fig. 2C), thus confirming our findings of
β-galactosidase activity with Mrf4nlacZ/+:Myf5loxP/+ mice.
Nine days after culture, Mrf4 was detected by Western blot
in differentiated cells, and this expression was not upregulated
in the Myf5 null cultures (Fig. 2C). Therefore, Myf5 and
Myod appear to be the only MRFs acting in controlling the
early stages of satellite cell function.Compromised regenerative myogenesis in Myf5 null mice
Since Myf5 null mice exhibit signs of muscle degeneration
and regeneration, we sought to examine the role of Myf5
during regenerative myogenesis after acute injury. To do this,
the Tibialis anterior muscle of young adult mice (6–10 weeks
old) was damaged by freeze-injury (Figs. 3A–E). Muscles
were subsequently dissected and analysed up to 5 weeks later.
Anti-Pax7 staining revealed satellite cells tightly associated
with regenerating fibres and underneath the myofibre basal
lamina, although occasionally, Pax7+ cells were detected
outside the basal lamina after injury (Fig. 3B, right inset;
data not shown). Presently, we are not able to assess the fate of
these cells. Haematoxylin and eosin (H&E) staining of muscle
sections revealed large numbers of regenerating fibres, clearly
distinguishable by their basophilic cytoplasm and centrally
located nuclei, in both control and Myf5 null mice (Fig. 3A;
arrows; data not shown). However, a striking accumulation of
adipocytes was observed at the site of regeneration in Myf5
null mice, compared to controls. This phenotype was observed
with different allelic combinations of Myf5 nulls (Fig. 3A,
quantified in table; Supplementary Fig. 1A, B). Fat accumula-
tion was rarely seen in control mice (Fig. 3A; data not shown).
Furthermore, fibrosis of the endomysium of the connective
tissue was increased in injured Myf5 null (level 3; n=11 mice)
compared to control (level 0; n=3 mice) animals (data not
shown). Adipocyte accumulation and fibrosis were not
Fig. 2.Mrf4 is not expressed in satellite cells. (A) Anti-β-galactosidase and anti-Pax7 antibody, or X-gal staining of freshly isolated single EDL fibres fromMrf4nlacZ/+:
Myf5loxP/+mice. Mrf4 is expressed in all myonuclei but not in quiescent satellite cells (arrow). X-gal staining of myonuclei quenches Hoechst staining and reveals only
the satellite cell (arrow) which is X-gal-negative. (B)Mrf4 (β-gal) expression accumulates in myonuclei of newly formed myotubes. (C) Western blot of Mrf4 protein
accumulation in satellite cell-derived cultures. Mrf4 protein is not detected in early primary myoblast cultures. Mrf4 is not up-regulated in cultures of Myf5-deficient
myoblasts postnatally. Samples were normalised using anti-tubulin antibody. Scale bars: A, 30 μm; B, 50 μm.
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animals (data not shown). In addition, higher calcium deposits
were observed in the Myf5 null mutants compared to controls.
Taken together, these findings suggest that muscle regeneration
may be compromised or delayed in Myf5 null animals. To test
this we examined two distinct muscle injury models, freeze and
cardiotoxin, and assayed for muscle regeneration and differ-
entiation at several time points after the injury. Accordingly, we
observed that muscle differentiation, as assessed morphologi-
cally and by the appearance of Myogenin-positive cells, was
delayed in the Myf5 null after freeze injury (Figs. 3B, C; at
3 days: n=2 controls, n=3 Myf5loxP/loxP; at 4 days: n=2 WT,
n=2 Myf5loxP/loxP). Seven days after injury, the numbers of
differentiated cells in the Myf5 null had recovered and slightly
higher than in the control, and this finding was confirmed by
neonatal MyHC staining at 14 days (Fig. 3C, n=3 WT, n=2
Myf5loxP/loxP; Supplementary Fig. 1C). Similar results were
obtained after cardiotoxin injury (data not shown).
Myofibre generation after injury in the Myf5 null was also
irregular compared to controls. The increase in myofibre
diameter and their increased heterogeneity in size 5 weeks
after freeze-injury provides further evidence that muscle
formation is compromised in Myf5 null animals. Strikingly,
this was about 2-fold greater for both parameters in
regenerating TA muscles from Myf5 null (n=5) compared to
control (n=5) mice (Fig. 3D). We note that the phenotype was
more pronounced with the Myf5loxP/loxP mice compared to
Myf5nlacZ/loxP (pb0.001). Since the mice are on a mixedgenetic background, it is possible that under some circum-
stances the phenotype is more severe. In summary, muscle
regeneration after acute freeze-injury was perturbed in Myf5
null mice, with the appearance of a severe dystrophic
phenotype characterised by endomysial fibrosis, muscle fibre
hypertrophy, and fat accumulation.
Satellite cell proliferation and differentiation appear normal in
Myf5 null mice
Some of the deficits mentioned above may be due to altered
properties of Myf5 null satellite cells. To investigate this
possibility, we used an ex vivo single fibre explant system and
examined the kinetics of myoblast production in adult (6–
10 weeks old) mice. Satellite cells, which were assayed by the
expression of Pax7 and Myf5nlacZ, were present in Myf5loxP/loxP
and Myf5nlacZ/loxP null mice with an average of 9–10 cells/fibre
on freshly isolated EDL myofibres (Figs. 4A, B), and 18 cells/
fibre on TA myofibres. Although a slight increase in satellite
cell number was observed in null animals, these values were not
statistically different (pN0.1) from controls (Figs. 4B, C; Shefer
et al., 2006; Zammit et al., 2002). To complement and confirm
these results we performed satellite cell counts on sections and
single fibres of 1-year-old Myf5 null animals. As with younger
animals, no significant differences were observed between
control and Myf5 mutant mice (Fig. 4C). Therefore, the loss of
Myf5 does not appear to affect satellite cell number in vivo.
Notably, the continued expression of β-galactosidase from the
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gene does not play a significant role in vivo in the adult, as we
showed for muscle progenitor cells in prenatal mice (Tajbakhsh
et al., 1996).
We also investigated satellite cell activation, migration,
proliferation, and differentiation capacity in the absence of
Myf5. Analysis of single-fibre-associated satellite cells, either
on the fibre in suspension or on the culture dish, showed no
significant difference in the activation of satellite cells in Myf5
null mice (98%), compared to controls (100%), as monitored by
the expression of Myod (data not shown). The proliferation
potential of Myf5 null satellite cells was evaluated using
multiple criteria. Single EDL myofibres were cultured on
Matrigel-coated dishes and myoblasts around the myofibre were
counted (t=72 h). No significant differences were observed
between control and Myf5 null satellite cells in their ability to
migrate away from the myofibre, or to generate myoblasts (Fig.
5A). Furthermore, differentiation, as evaluated by the percen-
tage of Myogenin-positive cells at 96 h and the generation of
large polynucleated myotubes, appeared normal (Figs. 5B, E).
Differentiation was also assessed on floating single myofibres.
Satellite cells from control and Myf5 null mice formed
numerous dispersed clusters of Pax7 and Myogenin expressing
cells by 72 h, and this was similar to control mice (data not
shown). In summary, Myf5 null satellite cells showed no
appreciable difference in activation, migration, proliferation or
differentiation compared to controls using single-fibre explant
assays.
To determine whether there might be a subtle defect in
proliferation in the Myf5 null, we assayed cell proliferation by
assessing the percentage of cells in mitosis and S-phase using
phospho-Histone3 and a BrdU pulse as indicators. No ap-
preciable difference was observed in the percentage of cells in
mitosis between wild-type and Myf5 null satellite cell derived
myoblasts (Supplementary Fig. 2A). However a significant
reduction in the percentage of satellite cells obtained from
single fibres that retained BrdU was observed in the Myf5 null,
with some mutants responding more severely that others (Fig.
5C; pN0.02). These findings lead us to reason that the
potentially compromised behaviour of Myf5 null satellite cells
within the microenvironment and tissue context in vivo was
perhaps masked by our culture conditions.
In addition, it was reported that newborn primary myogenic
cells (Montarras et al., 2000) have some reduction in
proliferative capacity. This was also the case in a more recent
study with Myf5 null adult animals (Ustanina et al., 2007). WeFig. 3. Regeneration deficits inMyf5−/− mice after acute injury. Tibialis anterior (TA)
to 5 weeks later. (A) ControlMyf5nlacZ/+mice with regenerating fibres (arrows) conta
of injury. Myf5nlacZ/loxP, Myf5loxP/loxP TA muscles show dramatically more fat accum
Myf5loxP/loxP shows fat cells (arrowheads) among regenerating fibres (arrows). Fat a
quantity of adipocytes within the muscle on H&E-stained sections (table). As examp
left: scheme representing TA muscle in contact with frozen source (yellow star). Z
demarcates the zones analysed by immunostaining. Left box (a), distal site correspon
site corresponding to regenerating zone 7 days after injury. Anti-Pax7 and anti-Myog
are associated with newly formed myotubes (left inset). Some Pax7+ cells were observ
staining 3, 4 and 7 days after freeze-injury showing lower numbers of Myogenin-
Myogenin-positive cells after freeze-injury. (D) Five weeks after regeneration,Myf5 n
bar: 100 μm.reasoned that the method of isolation or the substrate used to
grow the cells may influence satellite cell behaviour, and by
altering these criteria, a phenotype may be unmasked. We
therefore prepared satellite cells from bulk cultures of adult
control and Myf5 null mice and examined different substrates
including poly-D-lysine (matrix-poor), Matrigel (basement
membrane extracellular matrix), gelatin (hydrolysed collagen)
and collagen (Type I). In gelatin-coated dishes proliferation
assays with BrdU in primary culture (3 days in culture) showed
a significant reduction in the fraction of BrdU+/Myod+ cells in
the Myf5 null compared to controls (Fig. 5D; n=3 WT, n=3
Myf5loxP/loxP; p=0.01). This finding is in agreement with the
reduction in BrdU+ myogenic cells obtained from single fibres
(Fig. 5C). However, at later stages of culture, no difference in
BrdU+ or Myogenin+ cells was observed (Supplementary Fig.
2C) consistent with our observations using single myofibres
(Figs. 5A, B and E). To address this issue further, we examined
satellite cell proliferation on poly-D-lysine, a substrate lacking
in matrix components. Micro-colony assays did not show a
significant difference between control andMyf5mutant cultures
(Supplementary Fig. 2B). Furthermore, under our standard
culture conditions (20% serum/2% Ultroser) as well as with
media containing lower levels of growth factors (10% serum/
1% Ultroser), the colony sizes on the substrate were not
significantly altered between the control and the mutant. In the
majority of conditions tested, although some slight reductions
were sometimes observed in the number of BrdU+/Myod+ in
Myf5 null satellite cells compared to controls, these were not
statistically significant (data not shown). In summary, a
significant reduction in proliferation was observed with satellite
cells obtained from Myf5 null mice compared to controls, and
this with the gelatin substrate. Using Matrigel, collagen and
poly-D-lysine, some reduced proliferation was observed, but
this was not statistically significant.
Satellite cell number and distribution vary with distinct injury
paradigms
To understand the regeneration deficits in Myf5 null mice, it
is important to determine the numbers of satellite cells which
remained after freeze-injury. In this model, extensive muscle
damage is evident at the site of freezing (zone II), whereas
regenerating and non-regenerating fibres (Fig. 6A) are present
in the less damaged region (zone I). Nuclei and Pax7+ cells were
not detected in the damaged region (zone II), and a gradient of
Pax7 expression and nMyHC+ fibres was observed emanatingmuscle of young adult mice (6–10 weeks) were freeze-injured and examined up
ining centrally located myonuclei and some fat cells (arrowhead) close to the site
ulation in the regenerating area (arrowheads). Magnified view of boxed area of
ccumulation after freeze-injury was evaluated by visual observation of relative
les, for panel A, upper right (++++), lower left (+++), upper left (−). (B) Upper
one II=site of lesion. Zone I contains largely undamaged fibres. Dotted line
ding to regenerating zone 3 days and 4 days after injury. Right box (b), proximal
enin stainings indicate satellite and differentiated cells, respectively. Pax7+ cells
ed outside the basement membrane of fibres (right inset; arrowhead). Myogenin
positive cells in the mutant at 3 and 4 days after injury. (C) Quantification of
ull have larger diameter fibres adjacent to the regenerated area (pb0.0001). Scale
Fig. 4. Normal number of quiescent satellite cells inMyf5 null mice. (A) Anti-Pax7 and anti-β-galactosidase antibody stainings show satellite cells on freshly isolated
EDL myofibres fromMyf5nlacZ/+ control andMyf5nlacZ/loxP mice. (B) Average number of quiescent satellite cells/EDL myofibre from control (Myf5nlacZ/+; n=54), and
Myf5loxP/loxP (n=35); Myf5nlacZ/loxP (n=17), andMyod−/− (n=27) null young adult (6–10 weeks old) mice. Quiescent satellite cells were scored as Pax7+. n=number
of fibres from 2 mice. Scale bar: 20 μm. Average number of quiescent satellite cells/TA myofibre from control wild-type (n=85), andMyf5loxP/loxP (n=74), n=number
from 3 young adult (6–10 weeks old) mice. (C) Average of Pax7+ satellite cells on frozen TA sections from control (n=2: wild-type andMyf5loxP/+) and mutant (n=2:
Myf5loxP/loxP) 1-year-old mice. For each mouse, 4 sections were counted at 2 different levels in the muscle. No significant difference was observed between controls
and mutants (pN0.2). Average of Pax7+ satellite cells on isolated single fibres from EDL and TA muscles. For TA, no significant difference was observed between the
control mice (Myf5loxP/+, n=27 fibres; wild-type, n=24 fibres) andMyf5 null mutants (n=2 mice,Myf5loxP/loxP; n=28 and 25 fibres); pN0.2. For EDL, no significant
difference was observed between the control mice (Myf5loxP/+, n=26 fibres; wild-type, n=24 fibres) and Myf5 null mutants (n=2 mice, Myf5loxP/loxP; n=34 and 26
fibres); pN0.13.
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Fig. 5.Myf5 null satellite cells show some proliferative deficits in vitro dependent on tissue culture substrate. (A) The proliferative capacity of myoblasts was assayed
by counting cells spread around the myofibre at 72 h. Myf5−/− myoblasts (Myf5loxP/loxP, n=40; Myf5nlacZ/loxP, n=36) were similar in number to controls (Myf5nlacZ/+;
n=35). n=number of fibres plated in duplicate experiments, with 2 mice. p=0.13, control vs.Myf5loxP/loxP; p=0.09 control vs.Myf5nlacZ/loxP. (B) Differentiation was
assessed by anti-Myogenin antibody staining at 96 h. Myf5−/− (n=73) was similar to control (n=54); n=number of fibres counted from duplicate experiments done
with 3 mice each. (C) Number of myogenic cells in S phase obtained from single fibres, and grown on Matrigel, was obtained by a 2-h BrdU pulse. Results of three
independent experiments (triplicate with 1 mouse/experiment) with the percentage of BrdU positive cells/total cells counted; p=0.02. (D) Assay of proliferation at 72 h
of Myf5 null satellite cells obtained from bulk muscle and grown on 0.1% gelatin. First passage satellite cells were obtained from control (n=3 WT) and Myf5 null
(n=3Myf5loxP/loxP) animals. Experiment done in triplicate. Significant differences were obtained in experiment 1 between controls and mutants (p=0.01). (E)Myf5−/−
myoblasts fused and formed myotubes as in the control.Myod−/− myoblasts are severely delayed in differentiation and fusion, and by 3 weeks they formed numerous
thin myotubes Bar=30 μM.
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data not shown). Therefore the undamaged zone I appears to be
the source of new satellite cells for muscle regeneration in this
model. By contrast, after cardiotoxin injection, there is aFig. 6. Loss of satellite cells in distinct injury models. (A) Hoescht and laminin stainin
of cardiotoxin. Laminin staining (left panels) reveals persistent basement membrane w
after injury. Cell distribution is uniform after cardiotoxin administration. Freeze-inju
freeze-injury scheme) and Hoescht-positive cells, and a “dead” area (zone II). The
number of Pax7+ satellite cells was evaluated on cryosections. The section area repr
cells in the freeze-injured muscle were located in the undamaged or partially dama
locations in the muscle (n=2 mice for each injury model). (C) Pax7 antibody stain
located under the basement membrane, marked by anti-laminin staining. Scale bars:homogeneous distribution of cellular material within the muscle
bed (Fig. 6A). After freeze and cardiotoxin injury, a basal
lamina was observed as shown by anti-laminin staining.
However, we can not presently exclude the possibility thatg of normal and injuredMyf5nlacZ/+muscles 18 h after freeze-injury, or injection
ith all injury models. Hoescht staining (right panels) shows distribution of cells
red muscle has undamaged (zone I; distal to the site of injury, see Fig. 3B for
Laminin and Hoechst stainings do not correspond to the same section. (B) The
esents arbitrary units normalised to 100% for the undamaged control. All Pax7+
ged area (zone I). Counts were performed on 2–3 sections, and at 2 different
ing of undamaged and 18 h post-injured Myf5nlacZ/+ muscle shows Pax7+ cells
A, 150 μm; C, 30 μm.
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models. Cell counts 18 h after freeze-injury revealed an
approximate 85% loss of satellite cells (Figs. 6A, B). The
remaining satellite cells, assayed by the presence of Pax7- or
Myf5nlacZ-positive nuclei within the basal lamina, were confined
to zone I (Fig. 6C; data not shown). We note that our Pax7
staining at 18 h assessed the number of satellite cells remaining
after the muscle lesion before the first mitosis (Zammit et al.,
2002). Satellite cell loss using the freeze-injury model was
comparable to that after cardiotoxin injury (90% loss), however,
in the latter model, satellite cells were more evenly distributed
throughout the muscle section (Fig. 6A; data not shown). This
value compares to a 30-fold loss in satellite cells after
cardiotoxin injury in a previous report (Polesskaya et al.,
2003). Interestingly, with the cardiotoxin injury, similar
amounts of adipocyte infiltration were observed in control
and Myf5 null muscles, however these levels were below the
maximal levels reached in the Myf5 null freeze-injury model
(data not shown). We note that a recent study did not report this
phenotype, probably because the cardiotoxin and not the
topologically distinct injury was employed for the analysis
(Ustanina et al., 2007). Thus, in spite of similar numbers of
satellite cells remaining after cardiotoxin- and freeze-injury, the
phenotypic outcome was different, and a role for Myf5 was
unveiled only with the latter model. These observations
underscore the importance of investigating distinct injury
paradigms when examining regenerative myogenesis.
Myf5 plays an important role during chronic regenerative
myogenesis
Having examined acute muscle regeneration we next wished
to investigate the role of Myf5 in a genetic model for chronic
regeneration. Such cumulative regeneration can reveal subtle
changes missed by the synchronous, more traumatic events
elicited by acute injury. To do this, we crossed Myf5 null mice
with the dystrophic mouse model, Mdx4cv which lacks
functional Dystrophin due to a point mutation in exon 53 (Im
et al., 1996). Mdx4cv mouse muscle undergoes chronic cycles
of degeneration/regeneration, as shown by nMyHC expression
(Fig. 7D), necrosis, fibrosis, and centrally nucleated myofibres.
Interestingly, the extent of fibre hypertrophy and heterogeneity
in fibre size in Myf5 null mice was comparable to that of the
Mdx4cv (Fig. 7A), consistent with the notion that lack of
Myf5 results in a subtle myopathy. These phenotypes were
additive in Myf5−/−:Mdx4cv double mutants where fibre
diameter and heterogeneity in size were almost twice that of
wild-type mice. This finding is not in accordance with a recent
report suggesting that myofibre calibre (area) was reduced in
both Myf5 null and Myf5:Mdx double mutants (Ustanina et al.,
2007). The number of necrotic fibres as well as the size of the
necrotic foci were dramatically higher in Myf5:Mdx4cv double
mutants compared to the Mdx4cv mutants (Fig. 7B), whereas
necrotic fibres were observed only rarely in normal and Myf5
null animals (data not shown). Similarly, Myf5−/−:Mdx4cv
double mutants exhibited a 3- to 4-fold increase in the number
of nMyHC-positive fibres compared to theMdx4cv mutant, andover 200-fold more than wild-type or Myf5 null mice where
nMyHC-positive fibres were rarely observed (Figs. 7C, D; data
not shown). Fibrosis of the connective tissue was already
significantly elevated in Myf5 null mutants, and this was not
enhanced appreciably inMyf5:Mdx4cvmutants compared to the
single mutants (level 3, n=5 mice; data not shown). These
results were reproduced using two independent allelic combina-
tions of Myf5 null mice, in single and double mutant animals.
Similar results were obtained with the gastrocnemius and
diaphragm muscles (data not shown). Preliminary counts of
satellite cells from the TA and EDL of 6- to 8-week- and 1-
year-old mice revealed a slight increase in the number of
satellite cells in Mdx4cv mice, whereas Myf5−/−:Mdx4cv
satellite cell numbers were similar to the Mdx4cv or slightly
reduced. We conclude therefore that satellite cells are not
depleted in Myf5−/−:Mdx4cv mutants (data not shown).
Thus, as in the Mdx4cv dystrophic mouse model, Myf5 null
mice displayed more muscle hypertrophy, fibrosis, and central
nucleation over time. Whilst this deficit is additive in Myf5−/−:
Mdx4cv double mutants compared to the single mutants, fibre
necrosis and the presence of nMyHC-positive fibres were
synergistic in the double mutants. Taken together, these findings
indicate that repeated or chronic cycles of degeneration/
regeneration take place in adult Myf5 null mice, and that the
phenotypes associated with this pathology were significantly
more severe in Myf5−/−:Mdx4cv double mutants.
Discussion
Recently, we generated new alleles at theMyf5 andMrf4 loci
to investigate the role of these MRFs both during development
and in the adult (Kassar-Duchossoy et al., 2004). We showed
that Mrf4 acts to determine muscle identity in embryonic
muscle progenitors (Kassar-Duchossoy et al., 2004, 2005). This
raised the possibility that it might also do so in adult satellite
cells, but the lack of sensitive Mrf4 antibodies made addressing
this issue difficult (Zhou and Bornemann, 2001). Using Mrf4-
knock-in mice, we show here that Mrf4 is not expressed in
quiescent satellite cells, that it begins to be expressed during
differentiation, and that it is not upregulated in Myf5 null
satellite cells. These findings indicate that Myf5 and Myod are
the only MRFs acting in the early stages of satellite cell
activation.
In the absence of Myf5, adult skeletal muscle undergoes a
subtle, progressive myopathy with increased myofibre diameter
heterogeneity, increased central nucleation and fibrosis. Since
Myf5 is thought to be involved in satellite cell activation and
proliferation, this suggests that its absence slightly perturbs their
function and affects normal myofibre turnover, which is
gradually manifested as a mild but progressive myopathy.
Interestingly, this phenotype is reminiscent of the early stages of
myopathies in humans (Engel et al., 1994). However, in
combination with a lack of Dystrophin, it is clear that the
absence of Myf5 exacerbates the myopathy, thereby high-
lighting the role of Myf5 in regulating satellite cells during
chronic muscle regeneration. The role of Myf5 in satellite cell
function however, is different from that of Myod, since the
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2000; Yablonka-Reuveni et al., 1999) and Myod−/−:Mdx
mutants (Megeney et al., 1996) are for the most part distinct
from Myf5 null and Myf5−/−:Mdx4cv double mutants. Specifi-cally, the TA muscle of Myf5 null mice is not significantly
different from that of the wild-type, unlike Myod null mice
where muscle weight is markedly reduced (Megeney et al.,
1996) due to a delay in differentiation (White et al., 2000;
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action of Myod in satellite cells remains unknown. The
myofibre hypertrophy phenotype in Myf5 null animals is
greatly enhanced in Myf5−/−:Mdx4cv double mutants, and as
with Myf5 null mutants, a greater range in fibre diameter size is
evident compared to controls. Interestingly, the synergistic
increase in the number of regenerating fibres as well as necrosis
in these double mutants is in keeping with our findings with
injured muscles from Myf5−/− animals which reveal a role for
Myf5 during regeneration.
These effects on satellite cell function in vivo are consistent
with the finding that differentiation was delayed during early
regeneration in Myf5 null animals. In addition, although under
our standard culture conditions, satellite cell activation,
proliferation and differentiation appear normal, we noted a
reproducible reduction in the number of cells in S-phase in the
first days of primary culture. Interestingly, we observed also a
dependence on the tissue culture substrate, but reduction of the
serum or FGF in the medium did not enhance this phenotype in
the Myf5 null. Taken together, the effects are unexpected given
that Myf5 expression is restricted to dividing, but not
differentiated cells. Moreover, we proposed recently that Mrf4
and Myod can activate Myogenin to promote differentiation
(Kassar-Duchossoy et al., 2004), whereas Myf5 fails to promote
differentiation in Mrf4:Myod or Mrf4:Myod:Myogenin mutants
(Rawls et al., 1998; Valdez et al., 2000) suggesting that Myf5 is
not directly involved in the decision to differentiate per se. Both
plated adult satellite cells and on floating fibres with both alleles
ofMyf5 null mice behaved much like their control counterparts,
albeit, under certain conditions compromised proliferation was
observed, and consequently fewer transit amplifying myoblasts.
It is possible that the hostile regeneration microenvironment in
vivo leads to an amplification of this phenotype and conse-
quently an initial delay in differentiation. How this is related to
the muscle hypertrophy which we report for the Myf5 null after
injury and the uninjuredMyf5:Mdx4cv is currently not clear. Our
results are consistent with previous studies with satellite cells
from bulk muscle obtained from newborn (Montarras et al.,
2000) and more recently with adult (Ustanina et al., 2007)Myf5
null mice, although in those studies the reduced proliferation
phenotype was more pronounced in vitro. In the latter study, no
significant difference in satellite cell number was observed in
vivo, in agreement with our present analysis. However, a decline
of 50% in the proliferation rate was observed between 4 and
6 days after satellite cell culture on matrigen or collagen
compared to a reduction by 25–30% in the percentage of cellsFig. 7. Acute degeneration and regeneration inMyf5−/−:Mdx4cvmutants. (A) TA fibre
andMdx4cvmice.Myf5−/− andMdx4cv fibre diameter is greater compared with wild-ty
to single mutants (pb0.0001). Individual fibres are noted by points, standard de
are reproduced from Fig. 1B for facilitating comparisons. (B) Number and size of
Myf5nlacZ/loxP:Mdx4cv (n=2), andMdx4cv (n=2) mice (p=0.013). Necrotic area is exp
between control (Mdx4cv) vs. pooled double mutants. No significant difference wa
(p=0.12). (C) Scatter plot showing higher number of nMyHC-positive fibres indicatin
n=3, Myf5nlacZ/loxP:Mdx4cv) compared to controls (n=3 mice, Mdx4cv and n=4 m
animal. The p-value was calculated between control vs. pooled double mutants. (D)
showing sporadic individual or small groups of regenerating fibres. Significantly large
TA muscle sections. Two examples are shown. Scale bar: 200 μm.incorporating BrdU during a similar period in the present study.
Our analysis showed this decline in proliferation when primary
cells were grown on gelatin (hydrolysed collagen), but only a
subtle phenotype with Matrigel (matrix-rich substrate) and
collagen Type I. It is possible that the developmental state of
the cells, the culture media conditions, or the genetic backgound
could account for this discrepancy. In the study with the newborn
mice (Montarras et al., 2000), precocious differentiation aswell as
a reduced BrdU incorporation (50–75% from 4 to 5 days after
culture; 6–10 passages) was reported. Notably, these cells were
passaged several times, compared to once or twice in the present
study. Also, it is not clear to what extent this satellite cell
population contains foetal myoblasts. Moreover, newborn emer-
ging satellite cells are actively dividing, and not for the most part,
quiescent (Cardasis and Cooper, 1975). Interestingly, in Myf5 as
well as Myod null mice, there is a delay in regeneration, albeit
more severe in the latter. In the Myod null, twice the number of
satellite cells are observed (Megeney et al., 1996, and present
study), whereas the number of satellite cells on myofibres in the
Myf5 null was not significantly altered. This underscores a further
functional difference between Myf5 and Myod in satellite cells.
We also examined the role of Myf5 in acute muscle
regeneration where a large synchronous activation of many
satellite cells is elicited in response to a massive muscle trauma.
The most marked phenotype of Myf5 null mice after acute
freeze-injury is the delay in differentiation and widespread
presence of adipocytes within the regenerating muscle bed.
With the former, the delay was observed early and the difference
with the control was no longer noticable after 1 week. For the
adipocyte infiltration, we believe that this is a consequence of
the impaired regeneration resulting in the adventitious entry of
adipocytes into the regenerating muscle bed. Accordingly, we
found that conversion of Myf5 null satellite cells to adipocytes
in culture occurs at a relatively low frequency, and we did not
observe this phenomenon in vivo (Supplementary Fig. 1B; data
not shown), suggesting that this phenomenon is likely not due to
the conversion of Myf5 null satellite cells into adipocytes in
vivo. Nevertheless, it is interesting to note that other extreme
examples of this phenomenon include excessive adipocyte
accumulation in the absence of skeletal muscles prenatally
(Kablar et al., 2003), in Pax7 null mice during regeneration
postnatally (Kuang et al., 2006), and in Duchenne muscular
dystrophy patients (Engel et al., 1994).
Interestingly, the dramatic difference in the infiltration of
adipocytes between normal and Myf5 mutant mice was not
observed in another commonly used injury model employingdiameter (μm)was quantified in undamaged 7-month-old wild-type,Myf5loxP/loxP
pe (pb0.0001), and significantly greater inMyf5loxP/loxP:Mdx4cvmice compared
viation is represented by boxed area. Note that the wild-type and Myf5 null
necrotic foci, reflecting muscle degeneration, in Myf5loxP/loxP:Mdx4cv (n=3),
ressed in mm2, measuredwith a grid at 40× objective. The p-value was calculated
s observed in necrosis between Myf5loxP/loxP:Mdx4cv and Myf5nlacZ/loxP:Mdx4c
g a higher index of regeneration inMyf5−/−:Mdx4cv (n=2,Myf5loxP/loxP:Mdx4cv;
ice, Myf5loxP/+:Mdx4cv) mice (pb0.0001). At least 3–4 sections were stained/
Anti-nMyHC antibody staining of Mdx4cv TA muscle sections (6–8 weeks old)
r clusters of regenerating fibres are observed in the age matchedMyf5−/−:Mdx4cv
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differentiation was observed in both models. Notably, the bio-
logy of these two injury paradigms is quite distinct. Although
the freeze- and cardiotoxin-injury models provoke the death of
the majority of the satellite cells, as well as the muscle fibres,
the relative distribution of the remaining satellite cells after the
injury is distinct in the two models. Whilst toxin paradigms
result in a relatively uniform distribution of satellite cells
poised to affect muscle repair, in the freeze-injury model the
surviving satellite cells are confined to the undamaged portion
of the muscle mass, remote from the site of injury (Fig. 3B,
scheme). Therefore, in contrast to the cardiotoxin model,
satellite as well as supportive cells in the freeze-injury model
replenish the acellular zone from the healthy tissue which
remains. Furthermore, newly formed myofibres, as well all
their associated supportive cells, move into the zone of lesion
to affect regeneration and repair. This model also provides a
unique opportunity to monitor the extent to which satellite
cells migrate to generate new fibres. After 5 weeks of
regeneration, we estimate that the distance covered is about
2–3 mm. If we assume that the majority of satellite cells which
will affect muscle repair arise from original satellite cells
(Wagers and Conboy, 2005), our findings would support the
view that satellite cells or their daughters can migrate over
extensive distances (Jockusch and Voigt, 2003; Partridge et al.,
1978). In this light, it is possible that these properties of
satellite cells were subtly compromised in the Myf5 null in
vivo. We have shown that differentiation is delayed early
during regeneration in the Myf5 null. We have also shown that
under some conditions proliferation is compromised in the
mutant. It is not presently clear if these phenotypes affect
also cell migration. Indeed, in the freeze-injury model where
extensive satellite cell and myoblast migration are necessary
to reconstitute myogenesis adjacent to the site of injury, this
may be a determining factor in the phenotypic outcome. Our
preliminary studies do not reveal overt migration defects in the
Myf5 null using myofibre explants, however this has to be
examined with different substrates and under different
conditions to test this possibility in detail. Taken together,
our studies underscore the importance of using diverse injury
models when examining tissue reconstitution from satellite
cells during regenerative myogenesis in normal and mutant
mice.
Since robust Myf5 and Myod protein expression have not
been detected in quiescent satellite cells, one can speculate that
they are specified, but that their identity is not yet determined, as
is the case with muscle progenitor cells in the embryo that
change fate in the absence of Myf5, and prior to Myod
expression (Tajbakhsh et al., 1996). If this were true, Myf5 and
Myod would direct myoblast fate from adult satellite cells that
lack their expression, after the activation of these satellite cells.
This notion is in agreement with our observations that Myod
null and Myf5 null satellite cells can generate adipocytes
somewhat more efficiently compared to control cells in vitro
(unpublished observations).
During the completion of our work, the analysis of another
Myf5 null allele was reported (Ustanina et al., 2007). Althoughsome of the phenotypes are similar to ours, those in vivo were
more pronounced in our study, particularly necrosis and
degeneration in the Myf5−/−:Mdx4cv. Furthermore, the study
of Ustanina et al. (2007) reported a larger number of small
fibres and a lower number of larger fibres. By contrast, we
noted a greater spread in fibre diameter with a higher number of
large calibre fibres. These observations were made with older
Myf5 null animals, after muscle injury of the Myf5 null, as
well as with Myf5:Mdx4cv double mutants. In addition, this
phenotype in the present study was reproduced with two allelic
combinations ofMyf5 null animals. It is not presently clear how
to explain this discrepancy. Furthermore, we observed
increased fibrosis in the Myf5 null in older animals, which
was not reported in the other study. These latter phenotypes
were confirmed and compounded in Myf5−/−:Mdx4cv double
mutants in our study. Some of the differences between the two
studies could be attributed to differences in genetic back-
grounds as indicated above. Indeed we have noted that Myod
null animals are less viable on certain genetic backgrounds
(unpublished observations). Another difference could be due to
perturbations of Mrf4 in cis. We have previously shown that
Mrf4 is not perturbed with the Myf5loxP allele. This locus
contains multiple regulatory elements which are sensitive to
genetic manipulations at either the Myf5 or Mrf4 locus
(Carvajal et al., 2001). TheMyf5ΔloxP allele previously reported
(Kaul et al., 2000) and used in the recent study (Ustanina et al.,
2007) has a 3-kbp deletion in the intergenic region which
contains several enhancer elements (Carvajal et al., 2001), but
this allele did not appear to perturb global expression ofMrf4 at
least in adult resting muscle.
In summary, this study examines the role of the myogenic
determination gene Myf5 in adult muscle. Whereas the
determination role of Mrf4 is restricted to embryogenesis,
Myf5 plays a role during muscle homeostasis, and both acute
and chronic regenerative myogenesis. Accordingly, in com-
pound mutants lacking Myf5 and Dystrophin function, these
phenotypes are synergistic, thereby reinforcing the notion that
Myf5 plays a role during muscle regeneration. Some of these
phenotypes in the single as well as the double mutants are
different from those reported for Myod null mice. Thus, these
studies demonstrate that Myf5 and Myod play distinct roles in
adult regenerative myogenesis.
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